A biodegradable ocular implant for long-term suppression of intraocular pressure
Timolol maleate (TM) has been used for many years for the reduction of intraocular pressure (IOP) in glaucoma patients. However, the topical mode of administration (eyedrops) is far from optimal because of the issues of low bioavailability, high drug wastage, and lack of patient compliance. Suboptim...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| 其他作者: | |
| 格式: | Article |
| 語言: | English |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/83816 http://hdl.handle.net/10220/41450 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|